Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectives.

Current opinion in oncology - 1 Nov 2009

Falini Brunangelo, Sportoletti Paolo, Martelli Maria Paola

Abstract excerpt

PURPOSE OF REVIEW: Nucleophosmin (NPM1) gene mutations, which cause aberrant cytoplasmic expression of nucleophosmin (NPMc+), are the most frequent genetic alteration in acute myeloid leukemia (AML), being found in about 30% cases. The present review summarizes recent advances in the biology, diagnosis, prognosis and therapy of NPM1-mutated AML. RECENT FINDINGS: Diagnostic criteria of NPM1-mutated AML are...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Disease
Share to Base Sequence
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Leukemia, Myeloid

Share to Molecular Sequence Data

Share to Nuclear Proteins

Share to Nucleophosmin

Share to Prognosis

Source

Identifiers

PMID: 19770764
DOI: 10.1097/CCO.0b013e3283313dfa

Genes

NPM1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectives.PMID 19770764Read ↗

Acute myeloid leukemia with mutated nucleophosmin (NPM1): molecular, pathological, and clinical features.Semantic proximity Read ↗

Nucleophosmin (NPM1) mutations in adult and childhood acute myeloid leukaemia: towards definition of a new leukaemia entity.Semantic proximity Read ↗

NPM1-mutated acute myeloid leukemia: from bench to bedside.Semantic proximity Read ↗

Nucleophosmin 1 Mutations in Acute Myeloid Leukemia.Semantic proximity Read ↗

Biology and Management of Acute Myeloid Leukemia With Mutated NPM1.Semantic proximity Read ↗

Nucleophosmin 1: from its pathogenic role to a tantalizing therapeutic target in acute myeloid leukemia.Semantic proximity Read ↗

Nucleophosmin1 (NPM1) abnormality in hematologic malignancies, and therapeutic targeting of mutant NPM1 in acute myeloid leukemiaSemantic proximity Read ↗

Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features.Semantic proximity Read ↗

Nucleophosmin gene mutations in acute myeloid leukemia.Semantic proximity Read ↗

NPM1-rearranged AML: clinical features, molecular pathogenesis, and therapeutic perspectives.Semantic proximity Read ↗

Recent advances in AML with mutated NPM1.Semantic proximity Read ↗

NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.